Comparing stent placement plus medication versus medication alone for chronic coronary syndrome
Part of Heart & circulation clinical trials.
This study compares two approaches for treating chronic coronary syndrome (reduced blood flow to the heart causing chest pain). One approach combines a stent procedure with optimal medication, while the other uses only medications. The goal is to see which approach better prevents major heart problems over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 40 years old
- You must have had a heart catheterization showing a narrowed artery that could be treated with a stent
- You must have at least 50% narrowing in a major heart artery, or have certain test results showing reduced blood flow
- You must be able to understand and sign a consent form
- You must not have severe heart failure (ejection fraction less than 35%)
- You must not have had a heart attack or unstable angina in the last 6 months
- You must not have active bleeding or a bleeding disorder
- You must not have had bypass surgery or a fully blocked heart artery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of choosing blood thinners after a heart stent procedure. It aims to see if using an imaging-guided strategy leads to better outcomes than usual care.
This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.
This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.
This study looks at whether opening blocked heart arteries with a stent (a PCI procedure) works better than staying on heart medicines for people with weakened pumping function and certain types of heart failure. It may help patients by testing which approach best improves outcomes over time.
This study compares two ways of deciding how completely to open blocked heart arteries using drug-eluting stents. It aims to see which guidance approach improves results and safety for people with coronary artery disease who need a PCI (heart catheter procedure).
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.